United Therapeutics Corp (NASDAQ:UTHR)

170.92
Delayed Data
As of May 01
 +11.23 / +7.03%
Today’s Change
84.63
Today|||52-Week Range
190.29
+31.99%
Year-to-Date

Today’s Trading

Previous close159.69
Today’s open161.38
Day’s range157.20 - 173.70
Volume1,009,899
Average volume (3 months)677,072
Market cap$7.9B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+91.46%
Earnings growth (this year)+53.06%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+15.36%
P/E ratio47.5
Price/Sales4.84
Price/Book6.48

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+3.73+6.74%
RDYDr.Reddy's Laborator...+0.81+1.56%
OPKOPKO Health Inc+0.27+1.96%
IDXXIDEXX Laboratories I...+7.56+6.03%
Data as of 4:02pm ET, 05/01/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.40
Annual revenue (last year)$1.3B
Annual profit (last year)$340.1M
Net profit margin26.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers